Successful use of a selective serotonin reuptake inhibitor in a patient with multiple chemical sensitivities

被引：8
|
作者：
Andine, P
Ronnback, L
Jarvholm, B
机构：
[1] SAHLGRENS UNIV HOSP, INST CLIN NEUROSCI, DEPT NEUROL, S-41345 GOTHENBURG, SWEDEN
[2] NORRLAND UNIV HOSP, DEPT OCCUPAT MED, UMEA, SWEDEN
来源：
ACTA PSYCHIATRICA SCANDINAVICA | 1997年 / 96卷 / 01期
关键词：
citalopram; depression; multiple chemical sensitivities;
D O I：
10.1111/j.1600-0447.1997.tb09910.x
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
A 53-year-old man with multiple chemical sensitivities (MCS) received the selective serotonin reuptake inhibitor (SSRI) citalopram for treatment of depression. The treatment was successful and, in parallel to the remission of the depressive symptoms, all MCS symptoms vanished. This suggests that a subgroup of MCS patients may have an atypical depression, that they should be psychiatrically evaluated, and that antidepressive pharmacological treatment may be considered in cases of MCS.
引用
收藏
页码：82 / 83
页数：2
相关论文
共 50 条
  • [31] Selective serotonin reuptake inhibitor use and outcomes following cardiac surgery-a systematic review
    Sepehripour, Amir H.
    Eckersley, Martyn
    Jiskani, Amber
    Casula, Roberto
    Athanasiou, Thanos
    JOURNAL OF THORACIC DISEASE, 2018, 10 (02) : 1112 - 1120
  • [32] Effects of Perioperative Selective Serotonin Reuptake Inhibitor Use in Primary Total Hip and Knee Arthroplasty
    Bourget-Murray, Jonathan
    Parkar, Asif
    Railton, Pam
    Evaniew, Nathan
    Powell, James
    JOURNAL OF ARTHROPLASTY, 2022, 37 (03) : 454 - 459
  • [33] Switching Selective Serotonin Reuptake Inhibitors in Adolescents with Selective Serotonin Reuptake Inhibitor-Resistant Major Depressive Disorder: Balancing Tolerability and Efficacy
    Strawn, Jeffrey R.
    Mills, Jeffrey A.
    Croarkin, Paul E.
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2019, 29 (04) : 250 - 255
  • [34] Selective Serotonin Reuptake Inhibitor Treatment and Depression Are Associated with Poststroke Mortality
    Ried, L. Douglas
    Jia, Huanguang
    Feng, Hua
    Cameon, Randi
    Wang, Xinping
    Tueth, Michael
    Wu, Samuel S.
    ANNALS OF PHARMACOTHERAPY, 2011, 45 (7-8) : 888 - 897
  • [35] Reduction of central poststroke pain with the selective serotonin reuptake inhibitor fluvoxamine
    Shimodozono, M
    Kawahira, K
    Kamishita, T
    Ogata, A
    Tohgo, SI
    Tanaka, N
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2002, 112 (10) : 1173 - 1181
  • [36] Selective Serotonin Reuptake Inhibitor Pharmaco-Omics: Mechanisms and Prediction
    Nguyen, Thanh Thanh L.
    Liu, Duan
    Ho, Ming-Fen
    Athreya, Arjun P.
    Weinshilboum, Richard
    FRONTIERS IN PHARMACOLOGY, 2021, 11
  • [37] Selective serotonin reuptake inhibitor effects on neural biomarkers of perinatal depression
    Pawluski, Jodi L.
    Brain, Ursula
    Hammond, Geoffrey L.
    Oberlander, Tim F.
    ARCHIVES OF WOMENS MENTAL HEALTH, 2019, 22 (03) : 431 - 435
  • [38] N-methyl-citalopram: A quaternary selective serotonin reuptake inhibitor
    Bismuth-Evenzal, Yona
    Roz, Netta
    Gurwitz, David
    Rehavi, Moshe
    BIOCHEMICAL PHARMACOLOGY, 2010, 80 (10) : 1546 - 1552
  • [39] Selective serotonin reuptake inhibitor effects on neural biomarkers of perinatal depression
    Jodi L. Pawluski
    Ursula Brain
    Geoffrey L. Hammond
    Tim F. Oberlander
    Archives of Women's Mental Health, 2019, 22 : 431 - 435
  • [40] Selective serotonin reuptake inhibitor-induced rhabdomyolysis associated with irinotecan
    Richards, S
    Umbreit, JN
    Fanucchi, MP
    Giblin, J
    Khuri, F
    SOUTHERN MEDICAL JOURNAL, 2003, 96 (10) : 1031 - 1033
12345